Impact of the use of Kampo medicine in patients with esophageal cancer during chemotherapy:a clinical trial for oral hygiene and oral condition.
CONCLUSION: This clinical trial showed that Daiokanzoto might be effective in attenuating gingival inflammation and reducing the levels of periodontopathogenic bacteria in patients with esophageal cancer. J. Med. Invest. 65:184-190, August, 2018.
PMID: 30282858 [PubMed - in process]
Source: Journal of Medical Investigation - Category: General Medicine Tags: J Med Invest Source Type: research
More News: Campylobacter | Cancer | Cancer & Oncology | Chemotherapy | Clinical Trials | Esophagus Cancer | Fusobacterium | Gastroenteritis | General Medicine | Oral Cancer | Study